- Health AI Insights
- Posts
- ☀️ A Decision AI Can't Predict
☀️ A Decision AI Can't Predict
Plus: More states are considering allowing medically assisted death
Welcome to your briefing:
AI ROUNDUP: VR therapy takes veterans back to virtual Vietnam to heal
INDUSTRY ROUNDUP: More states are considering allowing medically assisted death
WELLNESS BYTES: You can’t reverse the aging process but these 5 things can help you live longer
INSIGHTS CORNER: Gen Z's AI edge in the workforce
TRIVIA: In 2018, a study showed AI could predict genetic disorders from facial photos, aiding early diagnosis of rare conditions. What is this AI technology called?
AI ROUNDUP
WATCH THIS
Ultrasound sticker: A new stamp-sized ultrasound sticker developed by MIT can help monitor organ stiffness and detect diseases and tumor progression.
— ### —
Ok… Now back to AI roundup
End-Of-Life: The one decision AI cannot predict (Read More)
Google banishes Bard chatbot for AI rebrand as Gemini (Read More)
VR therapy takes veterans back to virtual Vietnam to heal decades-old trauma: A path to peace (Read More)
Nvidia CEO: AI Revolution Won’t Cost $7 Trillion (Read More)
Bain & Company: How to successfully scale generative AI in pharma (Read More)
US researchers engineer tiny earrings to track stress, periods, and more (Read More)
Samsung's galaxy watch gets FDA approval for sleep apnea (Read More)
Behind the Times: Washington tries to catch up with AI’s use in healthcare (Read More)
FDA clears Viz.ai algorithm for quantifying Intracerebral Hemmorhage (Read More)
INDUSTRY ROUNDUP
The Bill Gates problem: do billionaire philanthropists skew global health research? (Read More)
More states are considering bills allowing medically assisted death this year (Read More)
Pharma showed up for the big game (Read More)
States target health insurers’ Prior Authorization red tape (Read More)
Biotech bankruptcies hit 10-year peak in 2023 (Read More)
WELLNESS BYTES
FROM OUR PARTNERS
Don't struggle with weight loss anymore. Get medical help from WeightCare. Join thousands who have lost weight with Semaglutide. Start your transformation today!
INSIGHTS CORNER
#1- Gen Z's AI edge in the workforce
Gen Z's approach to AI diverges markedly from previous generations' concerns, viewing AI as an empowering tool rather than a threat. This generation is actively embedding AI into their academic and professional pursuits, showcasing a forward-thinking mindset that leverages technology for career advancement.
Key Findings:
Adoption and Planning: A notable portion of upcoming graduates, specifically one-third of the 2024 cohort and more than half of those in tech disciplines, are strategically planning to utilize AI in their professional lives.
Career Enhancement: Around 48% of Gen Z individuals recognize AI's potential to significantly speed up career progression by enabling faster access to crucial knowledge.
Skill Development: A 75% uptick in the mention of AI skills on LinkedIn among Gen Z profiles in 2023 underscores a proactive push towards acquiring technological competencies.
Optimism Over Anxiety: The data reveals a strong trend of optimism among Gen Z, with 57% expressing more excitement about the possibilities AI offers than concern over its risks, a sentiment echoed by 62% of millennials.
Significance:
Contrary to the prevailing view that AI could lead to job losses, Gen Z's proactive use of AI suggests a broader acceptance and enthusiasm for technology as a key part of their career toolkit. This shift among the younger generation indicates a workplace evolution where AI is seen as an integral component for professional growth, echoing the transformative impact of the internet and email for previous generations.
#2 - How common is generative AI among leading biopharmaceutical firms?
Generative AI is reshaping healthcare, delivering unprecedented productivity and efficiency gains. And generative AI adoption is more common than you might think!
Take a look at the numbers:
Key Findings:
Lucrative Opportunities: The AI-driven drug discovery platform, Genesis Therapeutics, secured a $200 million Series B funding backed by major investors, including Andreessen Horowitz, Fidelity, and BlackRock. Opportunity abounds!
Administrative Efficiency: Providers adopting generative AI could see a significant reduction in administrative costs by streamlining patient documentation and communication.
Drug Development Speed: Pharma and research entities utilizing AI can expect to accelerate drug discovery timelines. We are already seeing this with strategic partnerships like Sanofi and BioMap.
Claims Processing: Insurers implementing AI in claims management are projected to improve processing efficiency, optimizing patient experience and operational costs.
Diagnostic Advancements: Medtech investment in AI-powered diagnostics aims to boost disease detection accuracy, enhancing patient care and treatment outcomes.
Significance:
By embracing generative AI across various healthcare sectors, stakeholders can achieve significant operational improvements and unlock new potentials in treatment and diagnostics, positioning themselves at the forefront of healthcare innovation.
#3- Surgical AR on Apple Vision Pro
AI TRIVIA
In 2018, a study showed AI could predict genetic disorders from facial photos, aiding early diagnosis of rare conditions. What is this AI technology called? |
HEALTHCARE CONFERENCES
MARCH
March 8-12: SXSW Health and MedTech Track 2024 (Austin, TX)
March 11-15: 2024 HIMSS Global Health Conference (Orlando, FL)
March 11-12: Fierce BD&L Summit for Life Sciences (San Francisco, CA)
March 12-15: Health Industry Distributors Association (HIDA) Executive Conference (Amelia Island, FL)
March 12-14: AHIP 2024 Medicare, Medicaid, Duals & Commercial Markets Forum (Baltimore, MD)
March 18-20: Fierce Trial Master File Summit (Savannah, GA)
March 21: STAT 2024 Breakthrough Summit East (NYC & virtual)
March 25-28: American College of Healthcare Executives Congress on Healthcare Leadership (Chicago, IL)
That’s all for today, follow me on Linkedin. Support us by sharing our newsletter with your colleagues. Until next time. |
What'd you think of today's email? |